The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts aimed towards commercial product development in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports genomics research developing innovative analytical and computational commercial products, methodologies, and approaches, early stage development of commercial tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems.
Deadlines:
- Letter of Intent Due Dates: 30 days prior to the application due date
- Application Due Dates: Sep. 5, Jan. 5, Apr. 5
PAR-19-061 Expiration Date September 6, 2021
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.